[ad_1]
Clinical trials are an essential component of health care. They help ensure that new medicines or treatments are safe and effective, and they offer hope for cures to debilitating diseases.
Yet a lack of diversity in clinical trials is a serious issue with significant health implications. People of color, including Asian American and other racial groups, make up 40% of the general population in the U.S. Yet clinical trial participation skews heavily White—in some cases, 80% to 90%.
It is vital for all populations of people to be included when researching and developing new medications and treatments, and researchers are making strides towards more inclusive trials.
Learn more here.
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Subash Kafle
- Victor Mejia
- Victor Mejia
